Only Lyme disease vaccine in development goes to Phase 3 trial

Vaccine maker Pfizer says it has begun Phase 3 clinical trial of its vaccine candidate against Lyme disease with French vaccine company Valneva SE.
http://dlvr.it/SWLyWK